Moreover, our immunofluorescence results showed a statistical correlation of 79% for the co-localization of PMI and ABCG2, suggesting that PMI may play a role in the treatment of colon cancer using LBP by modulating ABCG2. The gene discussed is ABCG2; the disease is malignant colon neoplasm.